Clinical trial NCT06880809: Bridge the Gap (BTG) - Black Youth Group
Official title: Bridging the Gap: A Collaborative Intervention Group for Black Youth at Risk for Suicide
Study type: INTERVENTIONAL
Overall status: NOT_YET_RECRUITING
Phase: NA
Conditions: Suicide Prevention
Keywords: Suicide Prevention
Black Youth
Collaborative Assessment & Management of Suicidality (CAMS)
Group Intervention
Lead sponsor: Children's Hospital Los Angeles
Sponsor class: OTHER
First posted: 2025-03-18
Enrollment: 16
Sex: ALL
Minimum age (years): 12
Maximum age (years): 17
Standard ages: CHILD
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: PREVENTION

Brief summary: The goal of this clinical trial is to develop and preliminarily test a culturally adapted suicide intervention specifically for black youth. The main question it aims to answer:

-To evaluate the feasibility and acceptability of the group, as well as the preliminary efficacy of the group for decreasing suicidal thoughts and behaviors and increasing protective factors such as hope, positive ethnic identity, and family and peer support.

Participants will be asked to attend 10-week group intervention and complete pre-treatment and post-treatment assessment measures.


Eligibility criteria: Inclusion Criteria:

* 12-17 years old
* Identify as Black or African American or being of African descent
* Have current suicidal ideation or suicidal ideation within the last 30 days
* Have assent from the adolescent participant and consent from an individual's caregiver or guardian to participate.

Exclusion Criteria:

* An active psychotic disorder or current psychosis symptoms
* No history of suicide attempt(s) or suicide ideation in the past 30 days
* Cognitive deficits or a medical condition diagnosed from a medical provider that precludes full understanding of study materials as assessed through an inability to complete the pre-treatment CAMS SSF \& SSP
* Caregivers, guardians, and/or the patient refuse to participate.

Primary outcomes:
measure: The Collaborative Assessment & Management of Suicidality - Suicide Status Form (SSF)
timeFrame: From pre-treatment until 3 months post-treatment, approximately 23 weeks.
measure: Ethnic Identity Scale (EIS)
timeFrame: From baseline until 3 months post-treatment, approximately 22 weeks.
measure: Living Ladder Scale
timeFrame: From baseline until 3 months post-treatment, approximately 22 weeks.
measure: Brief Suicide Cognitions Scale (B-SCS)
timeFrame: From baseline until 3 months post-treatment, approximately 22 weeks.
measure: Therapeutic Relationship Working Alliance Inventory, Short Revised (WAI-SR)
timeFrame: From baseline until 3 months post-treatment, approximately 22 weeks.
measure: Optimism and Hope Scale (OHS)
timeFrame: From baseline until 3 months post-treatment, approximately 22 weeks.
measure: Parent Readiness for Hospital Discharge Scale (RHDS)
timeFrame: From baseline until 3 months post-treatment, approximately 22 weeks.
measure: Group Cohesion Scale
timeFrame: From baseline until the beginning of post-treatment, approximately 10 weeks.
Secondary outcomes:
Other outcomes:
Locations:
Study officials:
affiliation: Children's Hospital Los Angeles
name: Tia Tyndal, PhD
role: PRINCIPAL_INVESTIGATOR
References: